Hongyu Wang
58 Zhongshan 2nd Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Downstaging therapy of intermediate-stage hepatocellular carcinoma: microwave ablation vs. surgical resection.
Journal: Frontiers in oncology
Published: April 29, 2026
Resveratrol derivative restores macrophage cholesterol homeostasis via stabilizing xanthine oxidoreductase in hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: March 25, 2026
SPP1+ Macrophages Promote Immunosuppression in Post-TACE Hepatocellular Carcinoma Involving Lactate-Induced Lactylation and Potential SPP1-CD44 Signaling.
Journal: Journal of hepatocellular carcinoma
Published: February 14, 2026
Triptolide impacts CSF1R expression and reprograms the suppressive function of myeloid-derived suppressor cells via targeting the ER stress pathway.
Journal: Cytokine
Published: August 11, 2025
Identification and validation of an explainable machine learning model for hepatocellular carcinoma at high risk: a retrospective multicenter cohort study.
Journal: International journal of surgery (London, England)
Published: June 05, 2025
Correction: Multiparametric MRI based deep learning model for prediction of early recurrence of hepatocellular carcinoma after SR following TACE.
Journal: Journal of cancer research and clinical oncology
Published: November 15, 2024
Multiparametric MRI based deep learning model for prediction of early recurrence of hepatocellular carcinoma after SR following TACE.
Journal: Journal of cancer research and clinical oncology
Published: June 06, 2024
Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study.
Journal: Frontiers in immunology
Published: October 21, 2023
The Antitumor Impact of Combining Hepatic Artery Ligation With Copper Chelators for Liver Cancer.
Journal: Clinical Medicine Insights. Oncology
Published: March 14, 2023
Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: June 25, 2022
Idarubicin-Loaded DEB-TACE plus Lenvatinib versus Lenvatinib for patients with advanced hepatocellular carcinoma: A propensity score-matching analysis.
Journal: Cancer medicine
Published: March 08, 2022
Last Updated: 09/26/2026